Human Immunodeficiency Virus (HIV) Infection
References
Citations
Triant VA, et al. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. Journal of Clinical Endocrinology and Metabolism. Available online: http://jcem.endojournals.org/cgi/rapidpdf/jc.2006-2190v1 (e-pub ahead of print).
Chaturvedi AK, et al. (2007). Elevated risk of lung cancer among people with AIDS. AIDS, 21(2): 207–213.
Centers for Disease Control and Prevention (2007). Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report, 17. Available online: http://www.cdc.gov/hiv/stats/hasrlink.htm.
U.S. Department of Health and Human Services (2007). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Adult and Adolescent Guidelines. Available online: http://www.aidsinfo.nih.gov/guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1.
Centers for Disease Control and Prevention (2005). Updated U.S. Public Health Services guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR, 50(RR-09): 1–17. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5409a1.htm.
Centers for Disease Control and Prevention (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Recommendations from the U.S. Department of Health and Human Services. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm.
Braithwaite RS, et al. (2008). Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model. Annals of Internal Medicine, 148(3): 178–185.
Other Works Consulted
American College of Obstetricians and Gynecologists (2004, reaffirmed 2006). Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. ACOG Committee Opinion No. 304. Obstetrics and Gynecology, 104(5): 1119–1124.
Antiretroviral Therapy Cohort Collaboration (2003). Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: Analysis of prospective studies. Lancet, 362(9385): 679–686.
Del Rio C, Curran JW (2005). Epidemiology and prevention of acquired immunodeficiency syndrome and human inmmunodeficiency virus infection. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed., pp. 1477–1484. Philadelphia: Elsevier.
Eron JJ Jr, Hirsch MS (2008). Antiviral therapy of human immunodeficiency virus infection. In KK Holmes et al., eds., Sexually Transmitted Diseases, 4th ed., pp. 1393–1421. New York: McGraw-Hill.
Havlir DV, O'Marro SD (2004). Atazanavir: New option for treatment of HIV infection. Clinical Infectious Diseases, 38(11): 1599–1604.
Kaufmann GR, et al. (2003). CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years. Archives of Internal Medicine, 163(18): 2187–2195.
Martinez E, et al. (2003). Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. New England Journal of Medicine, 349(11): 1036–1046.
Mocroft A, et al. (2003). Decline in AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377): 22–29.
Riddler SA, et al. (2003). Impact of HIV infection and HAART on serum lipids in men. JAMA, 289(22): 2978–2982.
 Go to previous section |  Go to top of page |  Go to next section |
| Author: | Maria G. Essig, MS, ELS | Last Updated: May 8, 2008 |
| Medical Review: | Caroline S. Rhoads, MD - Internal Medicine Peter Shalit, MD, PhD - Internal Medicine | |
 | ||
